Morphologic studies in a patient with homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency.
Biochemical and morphologic studies on a patient with homocystinuria due to a deficiency of 5, 10-methylenetetrahydrofolate reductase (EC. 1.1.1.68) were performed. The concentrations of homocystine in the patient's plasma and urine were 2.97 mumol/dl and 44.67 mumol/24 hr, respectively. Activities of 5, 10-methylenetetrahydrofolate reductase (expressed as nanomoles of formaldehyde formed per hr per mg of protein) in cultured skin fibroblasts and liver tissue were 0.53 (control: 5.14) and 0.00 (control: 13.80), respectively. The major abnormalities were found in the arterial bed, consisting of intimal hyperplasia, fragmentation, and disruption of elastic lamellae and subcellular changes in the endothelial cells. Extensive thrombosis was observed. The brain and the liver also showed widespread pathologic changes. In the former, neuronal loss and cellular damage were prominent and extensive. Diffuse demyelination with moderate astrocytosis was found; but demyelination was out of proportion to the vascular changes. Hirano bodies in the cortical neurons and crystalline and lamellar bodies in the Purkinje cells were observed. In the liver, there were fatty change and mild to moderate portal fibrosis. Bizarre, giant mitochondria and membrane-bound multivesicular bodies were found. Mild pathologic changes were also observed in the striated muscles and the kidneys. Focal fragmentation, disruption, and smearing of the Z discs and disorganization of the myofilaments were found in the skeletal muscles. The kidneys showed shrunken glomeruli, thickened basement membranes, and swelling of epithelial as well as endothelial cells.
D001011:Aorta / Q000473:pathology; D001158:Arteries / Q000473:pathology; D001921:Brain / Q000473:pathology; D002648:Child; D003711:Demyelinating Diseases / Q000473:pathology; D005234:Fatty Liver / Q000473:pathology; D005260:Female; D006712:Homocystinuria / Q000201:enzymology / Q000473:pathology*; D006801:Humans; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000172:deficiency*; D009130:Muscle, Smooth / Q000473:pathology; D009474:Neurons / Q000473:pathology; D010088:Oxidoreductases / Q000172:deficiency*; D011651:Pulmonary Artery / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013927:Thrombosis / Q000473:pathology
D010088:Oxidoreductases; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP)